• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ICPT

ICPT

Intercept Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD19.00

+0.04 (+0.21%)

Company Profile

CEO

Jerome B. Durso

IPO Date

2012-10-11

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$19.00

Prev. Close

$18.96

Day Low

$18.98

Day High

$19.01

52W Low

$8.82

52W High

$21.86

Market Cap

$0.79B

Volume

3.91M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

24.3%

Avg Negative

14.5%

Avg Neutral

61.2%

News Feed

Intercept's (ICPT) Q2 Loss Narrower Than Expected, Sales Beat

Zacks Investment Research·7/30/2021·↓ negative

Intercept Pharmaceuticals, Inc. (ICPT) CEO Jerry Durso on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·7/29/2021·↓ negative

Intercept Pharmaceuticals: Q2 Earnings Insights

Benzinga·7/29/2021·↑ positive

Intercept Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update

GlobeNewsWire·7/29/2021·↑ positive

Earnings Outlook For Intercept Pharmaceuticals

Benzinga·7/28/2021·↑ positive

Intercept Pharmaceuticals (ICPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks Investment Research·7/22/2021·↑ positive

Why Intercept Pharmaceuticals Stock Shed 19% of Its Value in the First Six Months of 2021

The Motley Fool·7/19/2021·↓ negative

Intercept to Announce Second Quarter 2021 Financial Results on July 29, 2021

GlobeNewsWire·7/19/2021·↑ positive

Intercept to Present at the Raymond James 2021 Human Health Innovation Conference

GlobeNewsWire·6/15/2021·↑ positive

Intercept Appoints M. Michelle Berrey, M.D.

GlobeNewsWire·6/9/2021·↑ positive